Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)

Glioblastoma (GBM) is a highly aggressive primary brain tumor with dismal outcome for affected patients. Because of the significant neo-angiogenesis exhibited by GBMs, anti-angiogenic therapies have been intensively evaluated during the past years. Recent clinical studies were however disappointing,...

Descripción completa

Detalles Bibliográficos
Autores principales: Demeure, Kevin, Fack, Fred, Duriez, Elodie, Tiemann, Katja, Bernard, Amandine, Golebiewska, Anna, Bougnaud, Sébastien, Bjerkvig, Rolf, Domon, Bruno, Niclou, Simone P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2016
Materias:
Special Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739668/
https://www.ncbi.nlm.nih.gov/pubmed/26243272
http://dx.doi.org/10.1074/mcp.M115.052423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739668/
https://www.ncbi.nlm.nih.gov/pubmed/26243272
http://dx.doi.org/10.1074/mcp.M115.052423

Ejemplares similares